Jade Biosciences Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: JBIO
Share price (11/9/26): $15.60
Market cap (11/9/26): $992 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 9 pages Plan of Conversion

from 425 189 pages Agreement and Plan of Merger by and Among Aerovate Therapeutics, Inc., Caribbean Merger Sub I, Inc. Caribbean Merger Sub II, LLC and Jade Biosciences, Inc. Dated as of October 30, 2024

from 8-K 189 pages Agreement and Plan of Merger by and Among Aerovate Therapeutics, Inc., Caribbean Merger Sub I, Inc. Caribbean Merger Sub II, LLC and Jade Biosciences, Inc. Dated as of October 30, 2024